Skip to main content
LEEEF
OTC Life Sciences

CFO Buys $106K in LEEEF Shares, Reinforcing Confidence After Turnaround & Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.175
Mkt Cap
$49.091M
52W Low
$0.105
52W High
$0.257
52W Position info
68% above low
Off High info
32% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

LEEEF sits 68% above its 52-week low of $0.105.

Summary

Leef Brands' Chief Financial Officer and Director, Kevin John Wilson, made an open market purchase of $106,765 in common shares, signaling strong executive confidence following recent positive operational and financing news.


Key Events · Ownership and Investor Activity · LEEEF

  • CFO Open Market Purchase

    Kevin John Wilson, Chief Financial Officer and Director, purchased 464,197 common shares for a total of $106,765.31 at a price of $0.23 per share on June 15, 2026.

  • Significant Insider Conviction

    This open market purchase represents 0.217% of the company's market capitalization, signaling strong confidence from a key executive who is directly investing personal capital.

  • Follows Recent Positive Developments

    The purchase comes after Leef Brands reported a strong operational turnaround in Q1 2026, including improved gross margins and a return to operating profit, and recently completed a $9.3 million financing round.


Analysis · LEEEF · Life Sciences

This Form 4 filing reports a significant open market purchase by Kevin John Wilson, the Chief Financial Officer and a Director of Leef Brands Inc. The $106,765 purchase of common shares represents a direct investment of personal capital, indicating strong conviction in the company's prospects. This transaction is particularly notable as it follows a period of positive developments for Leef Brands, including a reported operational turnaround in Q1 2026, improved gross margins, and the recent completion of a $9.3 million financing round. Such an insider buy from a key executive suggests that management believes the company is on a positive trajectory.

At the time of this filing, LEEEF was trading at $0.18 on OTC in the Life Sciences sector, with a market capitalization of approximately $49.1M. The 52-week trading range was $0.10 to $0.26. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LEEEF - Latest Insights

LEEEF
Jul 24, 2026, 4:26 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.19818
Real-time Price: $0.1965 info
Change: -$0.00168 (-0.85%) info
Market Cap: $60.002M info
LEEEF
Jul 08, 2026, 7:09 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.20414
Real-time Price: $0.1965 info
Change: -$0.00764 (-4%) info
Market Cap: $60.002M info
LEEEF
Jun 02, 2026, 3:56 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.160
Real-time Price: $0.1965 info
Change: +$0.0365 (+23%) info
Market Cap: $60.002M info
LEEEF
May 06, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.162919
Real-time Price: $0.1965 info
Change: +$0.033581 (+21%) info
Market Cap: $60.002M info
LEEEF
May 05, 2026, 1:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1612
Real-time Price: $0.1965 info
Change: +$0.0353 (+22%) info
Market Cap: $60.002M info